BioMed Research International / 2019 / Article / Tab 1

Clinical Study

Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels

Table 1

Baseline characteristics of the entire patients (n = 427).

CharacteristicsNo. of patientsProportion (%)

Age (years), mean ± SD56.7 ± 9.5
Virus hepatitis
 Non-HBC, non-HCV6014.0
Antiviral treatment
ALT (U/L), median (IQR)36.0 (25.0–51.0)
T-Bil (umol/L), median (IQR)14.8 (11.2–19.4)
Anatomical resection
Surgical margin (mm)
MTD (cm)
Number of nodules
Microvascular invasion
 Mod, poor37788.3
TNM stage

HBV, viral hepatitis B; HCV, viral hepatitis C; ALT, alanine transaminase; T-Bil, total bilirubin; MTD, maximal tumor diameter; IQR, interquartile range. In this study, out of a total of 427 patients, 359 were HBV-related HCC patients. They were all treated with nucleic acid analog for hepatitis B. TNM stages were assigned according to the criteria described in the AJCC Cancer Staging Manual (8th Edition).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.